Media
Follow our progress and stay up to date with our press releases and media coverage.
Press Releases
Geneventiv Therapeutics Licenses Gene Therapy for Hemophilia
GeneVentiv Therapeutics and University of North Carolina Chapel Hill Enter License Agreement RALEIGH, NC, November 2, 2020 — GeneVentiv Therapeutics, Inc. has entered into a license agreement with the University of North Carolina Chapel Hill for a patent pending, gene...
In the News
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.